Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling

Endocrinology
Noelle E GillisFrances E Carr

Abstract

Thyroid hormone receptor β (TRβ) suppresses tumor growth through regulation of gene expression, yet the associated TRβ-mediated changes in chromatin assembly are not known. The chromatin ATPase brahma-related gene 1 (BRG1; SMARCA4), a key component of chromatin-remodeling complexes, is altered in many cancers, but its role in thyroid tumorigenesis and TRβ-mediated gene expression is unknown. We previously identified the oncogene runt-related transcription factor 2 (RUNX2) as a repressive target of TRβ. Here, we report differential expression of BRG1 in nonmalignant and malignant thyroid cells concordant with TRβ. BRG1 and TRβ have similar nuclear distribution patterns and significant colocalization. BRG1 interacts with TRβ, and together, they are part of the regulatory complex at the RUNX2 promoter. Loss of BRG1 increases RUNX2 levels, whereas reintroduction of TRβ and BRG1 synergistically decreases RUNX2 expression. RUNX2 promoter accessibility corresponded to RUNX2 expression levels. Inhibition of BRG1 activity increased accessibility of the RUNX2 promoter and corresponding expression. Our results reveal a mechanism of TRβ repression of oncogenic gene expression: TRβ recruitment of BRG1 induces chromatin compaction and dimini...Continue Reading

References

Jun 23, 2001·Oncogene·C Muchardt, M Yaniv
Aug 18, 2004·Molecular and Cellular Biology·Susana García-Silva, Ana Aranda
Dec 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Huiling HeAlbert de la Chapelle
Feb 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Fumihiko FuruyaSheue-yann Cheng
Feb 28, 2008·Nuclear Receptor Signaling·Kevin W Trotter, Trevor K Archer
Jan 17, 2009·Cancer Research·Olaia Martínez-IglesiasAna Aranda
Jun 16, 2009·Molecular and Cellular Endocrinology·Inna AstapovaAnthony N Hollenberg
Sep 1, 2009·Trends in Endocrinology and Metabolism : TEM·Ana ArandaAlberto Zambrano
Jan 30, 2010·Nature·Lena Ho, Gerald R Crabtree
Jun 10, 2011·Nature Reviews. Cancer·Boris G Wilson, Charles W M Roberts
Dec 24, 2011·Acta Biochimica Et Biophysica Sinica·Jiang I Wu
Apr 18, 2012·Biochimica Et Biophysica Acta·Won Gu Kim, Sheue-yann Cheng
May 30, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Dong-Feng NiuRyohei Katoh
Jul 24, 2012·The Journal of Clinical Endocrinology and Metabolism·Valentina SancisiAlessia Ciarrocchi
Jan 29, 2013·PloS One·A Hunter Shain, Jonathan R Pollack
Jun 5, 2013·Thyroid : Official Journal of the American Thyroid Association·Won Gu KimSheue-yann Cheng
Nov 26, 2014·Molecular and Cellular Biology·Hiroaki ShimizuAnthony N Hollenberg
Mar 15, 2015·Cancer Research·Valentina SancisiAlessia Ciarrocchi
Mar 27, 2015·Journal of Cellular Physiology·Qiong WuAnthony N Imbalzano
Feb 16, 2016·The Journal of Clinical Investigation·Iñigo LandaJames A Fagin
May 8, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Olaia Martínez-IglesiasAna Aranda
Jul 9, 2016·The EMBO Journal·Ana Silvina NachtGuillermo P Vicent
Feb 12, 2017·Cell·James E BradnerRichard A Young

❮ Previous
Next ❯

Citations

Jun 20, 2020·Molecular Cancer Research : MCR·Eric L BolfFrances E Carr
Dec 14, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eric L BolfFrances E Carr
Jan 18, 2022·Nucleic Acids Research·Noelle E GillisFrances E Carr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.